Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-5-21
pubmed:abstractText
Regimens with prolonged infusions of taxanes have been developed for patients with cancer to overcome drug resistance. Our objective of the present study was to examine the impact of prolonged exposure on the cytotoxicity of taxanes against non-small-cell lung carcinoma (NSCLC) cell lines and the clinical response and outcome of the patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0030-2414
pubmed:author
pubmed:copyrightInfo
Copyright 2003 S. Karger AG, Basel
pubmed:issnType
Print
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
399-406
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:12759538-Adult, pubmed-meshheading:12759538-Antineoplastic Agents, Phytogenic, pubmed-meshheading:12759538-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:12759538-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:12759538-Female, pubmed-meshheading:12759538-Gene Expression Regulation, Neoplastic, pubmed-meshheading:12759538-Genes, MDR, pubmed-meshheading:12759538-Humans, pubmed-meshheading:12759538-Immunohistochemistry, pubmed-meshheading:12759538-Inhibitory Concentration 50, pubmed-meshheading:12759538-Lung Neoplasms, pubmed-meshheading:12759538-Male, pubmed-meshheading:12759538-Middle Aged, pubmed-meshheading:12759538-Multidrug Resistance-Associated Proteins, pubmed-meshheading:12759538-Paclitaxel, pubmed-meshheading:12759538-Phenotype, pubmed-meshheading:12759538-Polymerase Chain Reaction, pubmed-meshheading:12759538-Receptor, erbB-2, pubmed-meshheading:12759538-Taxoids, pubmed-meshheading:12759538-Tumor Cells, Cultured
pubmed:year
2003
pubmed:articleTitle
Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel.
pubmed:affiliation
Lowe Center for Thoracic Oncology, Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't